Literature DB >> 11240233

Influence of age on the results of brachytherapy for early tongue cancer.

H Yamazaki1, T Inoue, K Yoshida, A Imai, Y Yoshioka, E Tanaka, S Shimamoto, S Nakamura, T Inoue, H Nakamura, S Furukawa, K Shimizutani.   

Abstract

PURPOSE: To determine the influence of elder age on the results of brachytherapy for early (T1-2 N0 M0) oral tongue cancer and examine the compatibility of low-dose rate (LDR) with high-dose rate (HDR) brachytherapy. METHODS AND MATERIALS: We analyzed 591 patients treated at Osaka University Hospital between 1967 and 1999. We compared the results of radiotherapy for 156 elderly patients (137 LDR and 19 HDR) 65 years of age or older and 435 patients (383 LDR and 52 HDR) less than 65 years of age.
RESULTS: HDR brachytherapy showed the same local control rate as LDR brachytherapy (81% at 3 years). Elderly patients showed a poorer local control rate (75% at 3 years) than the younger group (83% at 3 years)(p = 0.002). Multivariate analysis identified age as the only prognostic factor for local control (p = 0.002).
CONCLUSIONS: HDR brachytherapy achieved the same result as LDR brachytherapy. However, the elderly patient showed a higher rate of local recurrence after brachytherapy.

Entities:  

Mesh:

Year:  2001        PMID: 11240233     DOI: 10.1016/s0360-3016(00)01454-1

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  2 in total

1.  Disease control using low-dose-rate brachytherapy is unaffected by comorbid severity in oral cancer patients.

Authors:  R Yoshimura; H Shibuya; K Hayashi; K Toda; H Watanabe; M Miura
Journal:  Br J Radiol       Date:  2011-01-11       Impact factor: 3.039

2.  Age is not a limiting factor for brachytherapy for carcinoma of the node negative oral tongue in patients aged eighty or older.

Authors:  Hideya Yamazaki; Ken Yoshida; Tadayuki Kotsuma; Yasuo Yoshioka; Masahiko Koizumi; Souhei Furukawa; Naoya Kakimoto; Kimishige Shimizutani; Tsunehiko Nishimura
Journal:  Radiat Oncol       Date:  2010-12-09       Impact factor: 3.481

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.